Rights Issue11 Aug 2026, 04:22 pm
Genpharmasec Ltd: No Deviation in Rights Issue Proceeds Use for Q1 FY27
AI Summary
Genpharmasec Ltd has filed a statement confirming no deviation or variation in the utilization of proceeds from its Rights Issue for the quarter ended June 30, 2026. The funds, amounting to ₹4,845.05 Lakhs raised on February 21, 2024, were allocated to acquiring equity shares in Derren Healthcare Private Limited, repaying borrowings, working capital, general corporate purposes, and issue expenses. The Audit Committee has reviewed the statement and found no comments. The company has utilized the funds as per the original objects stated in the Letter of Offer.
Key Highlights
- No deviation reported in Rights Issue proceeds utilization for Q1 FY27.
- Total funds raised were ₹4,845.05 Lakhs.
- Proceeds used for subsidiary acquisition, debt repayment, and working capital.
- Audit Committee reviewed and found no issues.
- Utilization aligns with original objects of the Rights Issue.
Price Impact
More from GENPHARMA